Epithelial ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
1224
|
129
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Febrile Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
919
|
110
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
High grade serous carcinoma
|
disease |
|
Neoplastic Process
|
118
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Serous Tubal Intraepithelial Carcinoma
|
disease |
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Metastatic human epidermal growth factor 2 positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2011 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2012 |
Diarrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
632
|
63
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Fatigue
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
760
|
67
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Petechiae of skin
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Sign or Symptom
|
54
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.040 |
None |
1.000 |
4 |
|
1989 |
2004 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2008 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Herpes Simplex Infections
|
group |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
645
|
11
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |